Article · 10 Sep 2026
Review articlePublished 1 Mar 2022
A Systematic Review of Off-Label Use of Memantine for Neuropsychiatric Disorders Other than Dementia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
We provide a review on detailed literature review on the off-label use of memantine for neuropsychiatric disorders other than dementia focusing primarily on the use and efficacy of memantine. We performed a search on PubMed, Medline, EMBASE, Google Scholar, Ovid Medline, Psyc INFO, CENTRAL, consultant 360 and reviewed reference sections of selected papers. We also drew data from reflections and clinical experiences of expert mental health practitioners.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Advances in Pharmacoepidemiology and Drug Safety.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalAdvances in Pharmacoepidemiology and Drug Safety
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Rochaknaveen S. Bains”
- BylineArticles whose byline prints “Manvir Kaur”
- BylineArticles whose byline prints “Raman Marwaha”
- BylineArticles whose byline prints “Kanwal Naveen Bains”
- BylineArticles whose byline prints “Rajesh Mehta”
- BylineArticles whose byline prints “Garima Garg”
